PXD073473 is an
original dataset announced via ProteomeXchange.
Dataset Summary
| Title | Compensatory Spliceosomal Reprogramming Underlies PRMT5 inhibitor Adaptation in Pancreatic Cancer Cells |
| Description | Pancreatic ductal adenocarcinoma (PDAC) remains a formidable clinical challenge. Next-generation protein arginine methyltransferase 5 (PRMT5) inhibitors show promising clinical results in a subset of PDACs with co-deletion of the tumor suppressor CDKN2A with the methylthioadenosine phosphorylase (MTAP) gene. However, primary and secondary resistance mechanisms limit the efficacy of this synthetic lethality approach. Our study reveals that compensatory spliceosomal reprogramming drives adaptation to PRMT5 inhibition in PDAC. Through comprehensive molecular profiling, we demonstrate that PRMT5 inhibitors induce marked upregulation of RNA-binding proteins, particularly RNA-binding protein 39 (RBM39), across diverse preclinical cellular models. We exploit this vulnerability by combining PRMT5 inhibition with Indisulam-mediated RBM39 degradation yielding synergistic activity. The combination strategy significantly enhanced apoptotic cell death and suppressed tumor outgrowth in resistance assays compared to single-agent treatments. We conducted multi-omics analysis revealing concomitant suppression of DNA repair machinery and metabolic pathways. Collectively, our work defines spliceosomal rewiring as a mechanism to limit cellular PRMT5 efficacy and nominates RBM39 as a therapeutically exploitable vulnerability, establishing the mechanistic foundation for dual targeting of the splicing machinery. |
| HostingRepository | PRIDE |
| AnnounceDate | 2026-07-28 |
| AnnouncementXML | Submission_2026-07-28_02:29:09.636.xml |
| DigitalObjectIdentifier | |
| ReviewLevel | Peer-reviewed dataset |
| DatasetOrigin | Original dataset |
| RepositorySupport | Unsupported dataset by repository |
| PrimarySubmitter | Christof Lenz |
| SpeciesList | scientific name: Homo sapiens (Human); NCBI TaxID: NEWT:9606; |
| ModificationList | No PTMs are included in the dataset |
| Instrument | timsTOF Pro 2 |
Dataset History
| Revision | Datetime | Status | ChangeLog Entry |
| 0 | 2026-01-23 13:04:14 | ID requested | |
| ⏵ 1 | 2026-07-28 02:29:10 | announced | |
Publication List
| Dataset with its publication pending |
Keyword List
| submitter keyword: pancreatic cancer, PRMT5, splicing, RBM39 |
Contact List
| Christof Lenz |
| contact affiliation | Core Facility Proteomics, Department of Clinical Chemistry, University Medical Center Goettingen, Germany |
| contact email | christof.lenz@med.uni-goettingen.de |
| lab head | |
| Christof Lenz |
| contact affiliation | Max Planck Institute for Biophysical Chemistry |
| contact email | christof.lenz@mpibpc.mpg.de |
| dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2026/07/PXD073473 |
| PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD073473
- Label: PRIDE project
- Name: Compensatory Spliceosomal Reprogramming Underlies PRMT5 inhibitor Adaptation in Pancreatic Cancer Cells